Pulmonx (LUNG) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulmonx (LUNG) has outperformed Outset Medical (OM) over the past year, gaining 1.7% versus a loss of 72.0%. Over five years, LUNG leads with a -95.5% price change compared with -99.4% for OM. Pulmonx is the larger company by market cap ($77.7 million vs $76.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUNG | OM |
|---|---|---|
| Share price | $1.81 | $4.09 |
| Market cap | $77.74M | $76.88M |
| 1-day change | -1.63% | -2.85% |
| YTD return | -18.10% | +13.48% |
| 1-year return | +1.69% | -71.95% |
| 5-year return | -95.45% | -99.42% |
| EPS (TTM) | $-1.19 | $-4.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.89 | $15.94 |
| 52-week low | $1.13 | $2.84 |
| Distance from 52-week high | -37.37% | -74.34% |
| Analyst consensus | none | buy |
| Avg. price target upside | +87.85% | +87.53% |
| Average volume | 477.26K | 158.75K |
| Shares outstanding | 42.95M | 18.80M |
| Employees | 296 | 310 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LUNG has outperformed OM by 73.6 percentage points over the past year.
About Pulmonx
LUNG stock →Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
Healthcare · Medical Devices · 296 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Healthcare · Medical Devices · 310 employees
LUNG vs OM FAQ
Which is bigger, Pulmonx or Outset Medical?
Pulmonx (LUNG) is larger, with a market capitalization of $77.74M compared with $76.88M for Outset Medical (OM).
Which stock has performed better over the past year, LUNG or OM?
LUNG returned +1.69% over the past 12 months, compared with -71.95% for OM (price return, excluding dividends). Past performance does not predict future results.
Are Pulmonx and Outset Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.